GlassScriptPhysician profile
Rick James Bucher
NPI 1972619443
$8,355.33
in general payments reported to CMS, 2019-2025
45 companies · $2,307 in 2025
The $2,307 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,440 · 2020: $1,178 · 2021: $1,731 · 2022: $53.19 · 2023: $173 · 2024: $1,474 · 2025: $2,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,954.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,816.17 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $936.97 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $658.76 | 2019-2025 | |
| Abbvie INC. | $519.84 | 2021-2025 | Ubrelvy |
| Lilly USA, LLC | $487.46 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Janssen Pharmaceuticals, INC | $442.52 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $315.19 | 2019-2025 | Jardiance, Synjardy |
| Exact Sciences Corporation | $294.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $282.97 | 2021-2025 | |
| Astellas Pharma US INC | $249.89 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $213.58 | 2019-2021 | |
| Abbott Laboratories | $208.34 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $207.92 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $165.49 | 2019-2021 | |
| Glaxosmithkline, LLC. | $164.29 | 2019-2025 | Trelegy Ellipta, Arexvy |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Bucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.